Toxicity drug screening assays antitumor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Cell Line, Tumor Tumor Cells, Cultured T-Lymphocytes, Cytotoxic CD8-Positive T-Lymphocytes Killer Cells, Natural Dendritic Cells Cell Line Lymphocytes, Tumor-Infiltrating Cells, Cultured T-Lymphocytes Liver Spleen HT29 Cells CD4-Positive T-Lymphocytes Kidney

Organisms15

Mice, Nude Mice, Inbred BALB C Mice, Inbred C57BL Mice, SCID Adenoviridae Oncolytic Viruses Mice, Inbred DBA Streptomyces Mice, Inbred C3H Mice, Inbred Strains Mice, Inbred ICR Mice, Transgenic Rats, Inbred F344 Rats, Sprague-Dawley Mice, Knockout

Diseases48

Leukemia P388 Neoplasms, Experimental Neoplasms Sarcoma 180 Melanoma, Experimental Leukemia L1210 Lung Neoplasms Melanoma Carcinoma, Lewis Lung Colonic Neoplasms Sarcoma, Experimental Fibrosarcoma Breast Neoplasms Neoplasm Metastasis Adenocarcinoma Mammary Neoplasms, Experimental Disease Models, Animal Neovascularization, Pathologic Leukopenia Ovarian Neoplasms Carcinoma, Ehrlich Tumor Neutropenia Kidney Neoplasms Prostatic Neoplasms Liver Neoplasms Drug-Related Side Effects and Adverse Reactions Brain Neoplasms Leukemia, Experimental Drug-Induced Liver Injury Carcinoma, Non-Small-Cell Lung Leukemia L5178 Lymphoma Radiation Injuries Hematologic Diseases Carcinoma, Renal Cell Thrombocytopenia Colorectal Neoplasms Glioma Nausea Pancreatic Neoplasms Head and Neck Neoplasms Carcinoma, Squamous Cell Body Weight Neuroblastoma Carcinoma Carcinoma, Hepatocellular Necrosis Stomatitis

Chemicals and Drugs91

Antineoplastic Agents Antibiotics, Antineoplastic Cancer Vaccines Antineoplastic Agents, Phytogenic Cisplatin Doxorubicin Antibodies, Monoclonal Enediynes Fluorouracil Camptothecin Paclitaxel Antigens, Neoplasm Angiogenesis Inhibitors Antineoplastic Agents, Alkylating Deoxycytidine Immunotoxins Prodrugs Cyclophosphamide Antimetabolites, Antineoplastic Taxoids Organoplatinum Compounds Drug Carriers Interleukin-2 Indoles Plant Extracts Quinazolines Recombinant Proteins Enzyme Inhibitors Ellipticines Interferon-gamma Liposomes Etoposide Antibodies, Monoclonal, Humanized Topoisomerase I Inhibitors Interleukin-12 Protein Kinase Inhibitors Vinblastine Naphthacenes Mitomycin Pyrroles Carboplatin Topotecan Dacarbazine Intercalating Agents Pyrazines Zinostatin Antibodies, Neoplasm Thiazoles Aminoglycosides Leucovorin Adjuvants, Immunologic Antidotes Phenylurea Compounds Pyridines Benzenesulfonates Methotrexate Nitrogen Mustard Compounds Plicamycin Niacinamide Boronic Acids Benzoquinones Bleomycin Glutathione Polyethylene Glycols Pyrimidines Aminoacridines Mitomycins Vincristine DNA Amsacrine Pyrazoles Radiation-Sensitizing Agents Anthraquinones Naphthoquinones Cytokines Recombinant Fusion Proteins Peptides Carmustine Platinum Aziridines Triazines Xanthones Dihydrouracil Dehydrogenase (NADP)Sulfonamides Drug Combinations Maytansine Reactive Oxygen Species Teratogens Melphalan Lactones Dioxoles

Analytical, Diagnostic and Therapeutic Techniques and Equipment62

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Toxicity Tests Toxicity Tests, Acute Neoplasms, Experimental Neoplasm Transplantation Melanoma, Experimental Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Lethal Dose 50 Immunotherapy Treatment Outcome Immunotherapy, Adoptive Combined Modality Therapy Transplantation, Heterologous Genetic Therapy Toxicity Tests, Chronic Maximum Tolerated Dose Administration, Oral Injections, Intralesional Infusions, Intravenous Oncolytic Virotherapy Inhibitory Concentration 50 Drug Evaluation, Preclinical Sarcoma, Experimental Tumor Burden Drug Evaluation Flow Cytometry Drug Carriers Mammary Neoplasms, Experimental Survival Analysis Disease Models, Animal No-Observed-Adverse-Effect Level Injections, Intraperitoneal Drug Delivery Systems Survival Rate Disease-Free Survival Injections, Intravenous Area Under Curve Blotting, Western Leukemia, Experimental Lymphocyte Activation Injections, Subcutaneous Transfection Immunotherapy, Active Radiotherapy Dosage Gene Transfer Techniques Toxicity Tests, Subchronic Body Weight Radioimmunotherapy Immunohistochemistry Organ Size Clinical Trials, Phase I as Topic Neoplasm Staging Radiotherapy Drug Design Magnetic Resonance Spectroscopy Drug Therapy, Combination Transduction, Genetic Remission Induction Clinical Trials as Topic Metabolic Clearance Rate

Phenomena and Processes37

Dose-Response Relationship, Drug Lethal Dose 50 Cell Survival Drug Synergism Apoptosis Cell Proliferation Time Factors Maximum Tolerated Dose Inhibitory Concentration 50 Cytotoxicity, Immunologic Cell Division Molecular Structure Genetic Vectors Structure-Activity Relationship Drug Resistance, Neoplasm No-Observed-Adverse-Effect Level Tissue Distribution Cell Death Signal Transduction Cell Cycle Area Under Curve Biotransformation Lymphocyte Activation Drug Interactions Tumor Escape Transfection Cell Growth Processes Body Weight Antibody-Dependent Cell Cytotoxicity Fermentation Organ Size Gene Expression Regulation, Neoplastic Transduction, Genetic Metabolic Clearance Rate Drug Resistance Necrosis Mutation

Disciplines and Occupations3

Toxicology Immunohistochemistry Drug Design

Technology, Industry, Agriculture3

Liposomes Nanoparticles Polyethylene Glycols

Information Science2

Survival Rate Molecular Sequence Data

Health Care8

Treatment Outcome Survival Analysis Survival Rate Disease-Free Survival Area Under Curve Radiation Injuries Clinical Trials, Phase I as Topic Clinical Trials as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Toxicity Tests Antineoplastic Agents Cell Line, Tumor Antibiotics, Antineoplastic Toxicity Tests, Acute Leukemia P388 Mice, Nude Neoplasms, Experimental Dose-Response Relationship, Drug Neoplasm Transplantation Neoplasms Sarcoma 180 Melanoma, Experimental Antineoplastic Combined Chemotherapy Protocols Mice, Inbred BALB C Cancer Vaccines Tumor Cells, Cultured Drug Administration Schedule Lethal Dose 50 Leukemia L1210 Antineoplastic Agents, Phytogenic Immunotherapy Cell Survival Drug Synergism Mice, Inbred C57BL Apoptosis Cisplatin Doxorubicin Lung Neoplasms Treatment Outcome Immunotherapy, Adoptive Antibodies, Monoclonal Cell Proliferation Combined Modality Therapy Mice, SCID Enediynes Fluorouracil Transplantation, Heterologous Melanoma Camptothecin Genetic Therapy Toxicity Tests, Chronic Time Factors Paclitaxel Maximum Tolerated Dose Administration, Oral Injections, Intralesional Carcinoma, Lewis Lung Antigens, Neoplasm Infusions, Intravenous Colonic Neoplasms Oncolytic Virotherapy Angiogenesis Inhibitors Inhibitory Concentration 50 Drug Evaluation, Preclinical Antineoplastic Agents, Alkylating Sarcoma, Experimental Deoxycytidine Immunotoxins Cytotoxicity, Immunologic Prodrugs Adenoviridae Tumor Burden Cyclophosphamide Antimetabolites, Antineoplastic Fibrosarcoma Cell Division Oncolytic Viruses Molecular Structure Genetic Vectors T-Lymphocytes, Cytotoxic CD8-Positive T-Lymphocytes Drug Evaluation Breast Neoplasms Killer Cells, Natural Taxoids Dendritic Cells Structure-Activity Relationship Drug Resistance, Neoplasm Neoplasm Metastasis Organoplatinum Compounds Flow Cytometry Mice, Inbred DBA Adenocarcinoma Drug Carriers Interleukin-2 Indoles Mammary Neoplasms, Experimental Survival Analysis Cell Line Disease Models, Animal Plant Extracts Lymphocytes, Tumor-Infiltrating Neovascularization, Pathologic Quinazolines Leukopenia Recombinant Proteins No-Observed-Adverse-Effect Level

No FAQ available that match "toxicity drug screening assays antitumor"